Zurueck zur Suche

Reporte zur Charge U015681

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

6Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
PA 2 WI 1 NH 1 TN 1 NY 1

VAERS 1804222

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015681

schwer
Staat
WI
Alter
13,0
Geschlecht
M
Eingang
21.10.2021
Impfdatum
21.10.2021
Beginn
21.10.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Immediate post-injection reaction Loss of consciousness Nervousness Syncope

Symptomtext

Immediately after receiving vaccinations, client fainted. He lost consciousness for approximately 45 seconds then regained consciousness. Client remained upright in the chair and no injury occurred. He drank water and ate crackers. Client and his mother reported he did not eat breakfast that morning and needles "made him nervous". After 15 minutes of close observation client was feeling "back to normal" and his mother drove him home. They were advised to have him eat more and watch for any other abnormal symptoms.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
N/A
Vorherige Impfungen
-

VAERS 1913083

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015681

mild
Staat
NH
Alter
1,0
Geschlecht
F
Eingang
01.12.2021
Impfdatum
15.11.2021
Beginn
24.11.2021
Tage bis Beginn
9,0
Dosis
1
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Rash Rash erythematous Rash maculo-papular Rash pruritic

Symptomtext

itchy erythematous maculopapular rash on torso and face. no swelling or discharge x 1 week. Rash erupted 9 days after vaccines were administered

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
atopic dermatitis
Andere Medikamente
sodium Fluoride daily; Triamcinolone PRN
Allergien
None
Vorherige Impfungen
-

VAERS 1905849

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015681

mild
Staat
PA
Alter
30,0
Geschlecht
F
Eingang
29.11.2021
Impfdatum
24.11.2021
Beginn
24.11.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Limb discomfort Pruritus Rash papular Skin reaction

Symptomtext

Raised skin reaction and itching. Some heaviness in the arm down to the hand. Was seen 2 days later at a clinic but only recommended to keep track of the reaction and if worsens to return.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pruritus
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
URI
Vorgeschichte
Hypothyroidism
Andere Medikamente
Levothyroxine, progesterone, fish oil, CoQ-enzyme, K2, B12, DHEA
Allergien
N/A
Vorherige Impfungen
Varicella (1st dose); shingles; 20; vaccine in 2011

VAERS 1727242

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015681

mild
Staat
TN
Alter
44,0
Geschlecht
F
Eingang
23.09.2021
Impfdatum
21.09.2021
Beginn
22.09.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Hypersensitivity Injection site erythema Injection site reaction Laboratory test Pyrexia Urticaria

Symptomtext

Allergic reaction to the Varivax # 2 vaccine that was given on 9-21-21. I have red, feverish, and welp around where the injection was given on my right upper arm on back side. After the shot was given on 9-21-21 & I had taken a Tylenol to help with the feverish & redness. The area has gotten a little bigger and I was told by RN that I needed to have this looked at by The ER physician. I was seen Hospital ER on 9-23-21 & was given IV Benadryl & antibiotic through IV along with the ER had drawn some lab work.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
Don't have these results back from the laboratory.
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2517539

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015681

gering
Staat
PA
Alter
1,0
Geschlecht
U
Eingang
28.11.2022
Impfdatum
04.11.2022
Beginn
04.11.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Overdose

Symptomtext

Caller reported VARIVAX and PROQUAD were administered to a 12 month old at the same visit. No other information provided. No Additional AEs or PQC reported.; Caller reported VARIVAX and PROQUAD were administered to a 12 month old at the same visit. No other information provided. No Additional AEs or PQC reported.; This spontaneous report was received from a nurse prescriber and refers to a 12-month-old patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 04-NOV-2022, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live, recombinant Human albumin (rHA) (PROQUAD) 0.5 milliliter (ml), lot # U031561, expiration date: 06-APR-2023, administered subcutaneously (SQ) for prophylaxis (strength was not provided), and varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 ml, lot # U015681, expiration date: 18-MAY-2023, administered subcutaneously for prophylaxis (strength was not provided) (Overdose) at the same visit. No other adverse event occurred (No adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2030885

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015681

gering
Staat
NY
Alter
-
Geschlecht
U
Eingang
13.01.2022
Impfdatum
20.12.2021
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

Vaccine administered after temperature excursion; No additional AE; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions, drugs reactions or allergies and concomitant therapies were not provided. On 20-DEC-2021, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck)(VARIVAX) with lot # U015681 and expiration date of 18-MAY-2023, at a dose of 0.5 milliliter, administered subcutaneously for prophylaxis (strength was not provided). The vaccine was exposed to a temperature excursion of 6.8?F with a time frame 8 hours and 5 minutes. There was no previous temperature excursion. No additional adverse events or product quality complaint (PQC) were reported. .

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-